Crossmark

Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?

Crossref DOI link: https://doi.org/10.1007/s00223-018-0409-1

Published Online: 2018-02-28

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anastasilakis, Athanasios D.

Tournis, Symeon

Yavropoulou, Maria P.

Polyzos, Stergios A.

Makras, Polyzois
License Information

Text and Data Mining valid from 2018-02-28
More Information

Article History

Received: 10 February 2018

Accepted: 26 February 2018

First Online: 28 February 2018

Compliance with Ethical Standards

:

: ADA has received lecture fees from Amgen, Eli-Lilly, ITF Hellas, VIANEX. PM has received lecture fees and research grants from Amgen; lecture fees from Eli-Lilly, Pfizer, ELPEN, VIANEX, UniPharma. ST, MPY, and SAP have nothing to declare.